Activation of inactive plasma renin by plasma and tissue kallikreins
- PMID: 41667
- DOI: 10.1042/cs0570351
Activation of inactive plasma renin by plasma and tissue kallikreins
Abstract
1. Normal human plasma contains a proactivator of inactive renin. The pro-activator is activated at physiological pH in plasma that has been pretreated with acid. This activation in vitro leads to the conversion of inactive renin into the active form with simultaneous generation of kallikrein activity. 2. The endogenous activator of inactive renin has the same pH profile and inhibitor spectrum as plasma kallikrein. 3. Inactive renin can also be activated by exposure of plasma to exogenous trypsin, and in normal plasma the quantities of inactive renin that are activated after acidification and with trypsin are identical. Prekallikrein (Fletcher factor)-deficient plasma, however, has much lower renin activity after acidification than with trypsin. Thus acid activation of inactive renin depends on plasma prekallikrein, whereas the action of trypsin is independent of prekallikrein. 4. Highly purified tissue (pancreatic) kallikrein, in a concentration of less than 2 X 10(-8) mol/l, activates inactive renin that has been isolated from plasma by ion-exchange chromatography. In this respect it is at least 100 times more potent than trypsin. 5. It is therefore possible that plasma and/or tissue (renal) kallikreins are also involved in the activation of inactive renin in vivo.
Similar articles
-
Activation of inactive plasma renin by tissue kallikreins.J Clin Endocrinol Metab. 1979 Nov;49(5):765-9. doi: 10.1210/jcem-49-5-765. J Clin Endocrinol Metab. 1979. PMID: 489716
-
Plasma kallikrein-mediated activation of the renin-angiotensin system does not require prior acidification of prorenin.J Clin Endocrinol Metab. 1982 Feb;54(2):343-8. doi: 10.1210/jcem-54-2-343. J Clin Endocrinol Metab. 1982. PMID: 6459340
-
Plasma active renin, inactive renin and kallikrein in patients with disseminated intravascular coagulation.J Formos Med Assoc. 1991 May;90(5):448-51. J Formos Med Assoc. 1991. PMID: 1680981
-
Renin requires a structural alteration prior to activation by renal kallikrein.J Clin Endocrinol Metab. 1980 Oct;51(4):942-4. doi: 10.1210/jcem-51-4-942. J Clin Endocrinol Metab. 1980. PMID: 6999004
-
Inactive renin: an attempt at a perspective.Clin Sci (Lond). 1981 Feb;60(2):119-30. doi: 10.1042/cs0600119. Clin Sci (Lond). 1981. PMID: 7016403 Review. No abstract available.
Cited by
-
The haemodynamic and humoral effects of treatment for one month with the angiotensin converting enzyme inhibitor perindopril in salt replete hypertensive patients.Eur J Clin Pharmacol. 1987;31(5):519-24. doi: 10.1007/BF00606623. Eur J Clin Pharmacol. 1987. PMID: 3030762 Clinical Trial.
-
Renin inhibition: a new modality for hypertension management.Curr Hypertens Rep. 2007 Aug;9(4):291-4. doi: 10.1007/s11906-007-0053-z. Curr Hypertens Rep. 2007. PMID: 17686379 Review.
-
Haemodynamic profile of captopril treatment in various forms of hypertension.Eur J Clin Pharmacol. 1981;20(3):163-8. doi: 10.1007/BF00544593. Eur J Clin Pharmacol. 1981. PMID: 7026256
-
A comparison of the haemodynamic and behavioural effects of moxonidine and clonidine in normotensive subjects.Br J Clin Pharmacol. 1992 Mar;33(3):261-7. doi: 10.1111/j.1365-2125.1992.tb04033.x. Br J Clin Pharmacol. 1992. PMID: 1576046 Free PMC article. Clinical Trial.
-
Studies with low dose intravenous diacid ACE inhibitor (perindoprilat) infusions in normotensive male volunteers.Br J Clin Pharmacol. 1992 Aug;34(2):115-21. doi: 10.1111/j.1365-2125.1992.tb04119.x. Br J Clin Pharmacol. 1992. PMID: 1419473 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources